Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01916733 · ClinicalTrials.gov registry record
A Quality Initiative to Improve Glycemic Control in Diabetic and Non-Diabetic Insulin Study
A clinical trial, sponsored by University of Vermont Medical Center.
- Completed
- Registry status
- 89
- Enrollment target
NCT01916733: Completed study, sponsored by University of Vermont Medical Center.
NCT01916733 is a clinical trial that has completed, run by University of Vermont Medical Center. The registered enrollment target is 89 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01916733 has completed, sponsored by University of Vermont Medical Center.
- COMPLETED
- Registry status
- 89 participants
- Enrollment target
Study Summary
The aim of this study is to examine the effect of moderate glucose (blood sugar) control in diabetic and non-diabetic patients undergoing leg bypass surgery (LEB) or open abdominal aortic aneurysm (AAA) repair. We hypothesize that use of Fletcher Allen Health Care's current insulin infusion strategy will result in improved blood sugar control which will translate into decreased postoperative morbidity (fewer complications) and better long term outcomes when compared to patient outcomes at other institutions which utilize other blood sugar management strategies.
Primary Outcome
1\. Glycemic control as measured by mean daily glucose levels and mean daily glucose excursions. We will look at the patients' finger-stick records and record the time spent at goal glucose levels, 80 to 150 mg/dL.
Interventions
- DRUG standard insulin protocol post-op (continuous IV insulin)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2013-01 |
| Est. Completion | 2016-06 |
What the finished NCT01916733 record still lists
NCT01916733 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 89 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which standard insulin protocol post-op (continuous IV insulin) is the first listed.
NCT01916733 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01916733 about?
NCT01916733 is a clinical study titled "A Quality Initiative to Improve Glycemic Control in Diabetic and Non-Diabetic Insulin Study". The aim of this study is to examine the effect of moderate glucose (blood sugar) control in diabetic and non-diabetic patients undergoing leg bypass surgery (LEB) or open abdominal aortic aneurysm (AAA) repair. We hypothesize that use of Fletcher Allen Health Care's current insulin infusion strategy...
What is the current status of trial NCT01916733?
This trial is currently completed. The enrollment target is 89 participants. The study started on 2013-01. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01916733?
The interventions under investigation include: standard insulin protocol post-op (continuous IV insulin) (DRUG).
Who is sponsoring clinical trial NCT01916733?
This trial is sponsored by University of Vermont Medical Center, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia